logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify’s first ultramodern laboratory on track

Financial reports, Investor News, News 2022-08-17
STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on […]
Read More

Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

Annual General Meeting, Investor News 2022-07-28
STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda […]
Read More

Notice to Extraordinary General Meeting in Inify Laboratories AB (publ)

Annual General Meeting, Investor News 2022-07-28
STOCKHOLM – July 28, 2022 – Inify Laboratories AB (publ) hereby invites its shareholders to en Extraordinary General Meeting on August 30th, 2022. Please find attached the invitation including agenda […]
Read More

Inify Laboratories announces the appointment of Chief Medical Officer (CMO)

Investor News 2022-06-29
Stockholm, June 29th 2022 Inify Laboratories announces the addition of specialized medical competence to the company’s management team and organization. “We warmly welcome Dr. Claes Lind to the role as […]
Read More

Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker

Investor News 2022-06-20
“Today I’m truly thrilled to announce that Inify Laboratories is admitted to trading on Euronext Growth Oslo, less than 5 months after we became independent. With solid funding of NOK […]
Read More

Inify Laboratories – Decision on admission to trading – Euronext Growth Oslo

Investor News 2022-06-16
Stockholm, June 16, 2022 Oslo Børs has decided to admit Inify Laboratories AB to trading. It is stipulated that the company prior to the first day of trading must satisfy […]
Read More

Inify Laboratories – Extended subscription period

Investor News, News 2022-05-30
STOCKHOLM – May 30th, 2022 Inify Laboratories AB has decided to extend the Subscription Period in the ongoing Subsequent Offering to 3 June 2022 at 16:30 hours (CEST). As a […]
Read More

Inify Laboratories – extra bolagsstämma 2022-05-09

Investor News, News, Swedish Investor News 2022-05-09
STOCKHOLM – 9 maj 2022 Inify Laboratories har hållit en extra bolagsstämma den 9 maj 2022. Bifogat finns en sammanfattning av de beslut som fattades vid den extra bolagsstämman. Vänligen […]
Read More

Inify Laboratories – kallelse till extra bolagsstämma

Investor News, News, Swedish Investor News, Uncategorized 2022-04-11
STOCKHOLM – 11 april 2022 Inify Laboratories bjuder härmed in sina aktieägare till en extra bolagsstämma den 9 maj 2022. Bifogat finns kallelse inklusive dagordning och information om hur man […]
Read More

Inify Laboratories AB becomes an independent company

Home, Investor News, News 2021-12-10
STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved […]
Read More
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories